Top Markets
Coin of the day
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
Classement en actions #32813
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
Prix de l'action
$2.22
Capitalisation boursière
$9.03M
Changement (1 jour)
-3.13%
Changement (1 an)
-21.92%
Pays
JP
Échange PhoenixBio Co., Ltd. (6190)

Catégorie

Historique du prix de l'action pour PhoenixBio Co., Ltd. (6190)
Prix de clôture le plus élevé : $2.26 le 2026-08-01

Prix de clôture le plus bas : $22.51 le 2016-03-01
Historique du prix de l'action de PhoenixBio Co., Ltd. de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -11.29%
2025 45.96%
2024 -30.54%
2023 -37.47%
2022 10.54%
2021 -19.56%
2020 -25.90%
2019 13.30%
2018 -31.36%
2017 -30.45%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$515.56 31.25%
US
$990.64 51.51%
NL
$736.64 7.19%
CH
$1.07K -6.40%
KR
$255.50 13.38%
BE